Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00016783 · ClinicalTrials.gov registry record
Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 39
- Enrollment target
NCT00016783: Completed study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
NCT00016783 is a clinical trial that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00016783 has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 39 participants
- Enrollment target
Study Summary
Some patients taking anti-HIV drugs as part of highly active antiretroviral therapy (HAART) do not show any HIV in the blood; however, some HIV will remain hidden in the body and, if the drugs are stopped, will return to the blood. The purpose of this study is to determine if short periods of stopping HAART increase the activity of CD8 and CD4 cells (cells of the immune system that fight infection), if repeated stopping of these drugs for longer periods of time and restarting them will increase effectiveness of HAART, and if the increased immune system activity as a result of stopping treatment leads to lower levels of HIV over time.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Est. Completion | 2006-10 |
What the finished NCT00016783 record still lists
NCT00016783 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 39 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00016783 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00016783 about?
NCT00016783 is a clinical study titled "Stopping and Restarting Anti-HIV Drugs in Children and Adolescents With Low Blood Levels of HIV". Some patients taking anti-HIV drugs as part of highly active antiretroviral therapy (HAART) do not show any HIV in the blood; however, some HIV will remain hidden in the body and, if the drugs are stopped, will return to the blood. The purpose of this study is to determine if short periods of stoppi...
What is the current status of trial NCT00016783?
This trial is currently completed. The enrollment target is 39 participants. Estimated completion is 2006-10.
Who is sponsoring clinical trial NCT00016783?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas